The main objective of this study was to determine the prevalence and antimicrobial resistance profiles of the main bacteria which are responsible for urinary tract, blood stream, cerebrospinal fluid, lower respiratory tract, and wound infections in Hamadan province in the west of Iran. Materials and Methods: In this study, a total of 773 urinary tract, 273 blood stream, 13 cerebrospinal fluid, 408 respiratory tract, and 147 wound positive samples were collected from patients who referred to Besat hospital from April 2013 to October 2014. Antibiotic susceptibility testing was performed by Modified Disk Diffusion Method (MDDM) against different classes of antibiotic. Results: The most common pathogens isolated from urine tract, blood stream, cerebrospinal fluid, lower respiratory tract, and wound infections were E. coli 425 (54.9%), S. aureus 68 (24.9%), Klebsiella spp. 3 (23%), P. aeruginosa 110 (26.9%), and S. aureus 30 (20.4%) respectively. The overall prevalence of resistance to the antimicrobial agents tested in various clinical specimens is discussed in this study.
Background
Bacterial infections are important causes of people mortality in the worldwide and disease-causing microbes that have become resistant to antibiotic therapy are a growing public health problem (1) (2) (3) . Bacterial blood stream infections (BSIs) are one of the most common nosocomial infections and annually about 200,000 cases of bacteremia occurs with morbidity and mortality rate in the range of 20-50% in the worldwide (4) . The timely and suitable use of antibiotics is the only way for treatment of bacteremia, however many of the bacterial pathogens are becoming resistant to the antimicrobial agents (4) .
Urinary tract infections (UTIs) after respiratory tract infections are the most common infectious diseases and nearly 10% of the global population experience a UTI in their lifetime (5) . Approximately 150 million UTIs occurs per year throughout the world (6) . Some studies have shown that the urinary pathogens such as E. coli, Klebsiella, Proteus, and Enterococcus species are the main causes of UTI in the community (7) . In most cases, empirical antimicrobial therapy is prescribed and for this purpose, it's extremely important to know the main bacteria which are involved in the UTIs and their antimicrobial resistance patterns (8, 9) .
Bacterial meningitis is an acute infection (inflammation of the meninges, arachnoid, and subarachnoid space) in response to bacteria and bacterial products (10) . This disease is a medical emergency that characterized with severe headache, fever, intolerance to light and sound, and stiffness of muscles especially neck muscles (10, 11) . In patients suspected to bacterial meningitis, empirical antimicrobial therapy is started within 60 minutes and without delay (12) . S. pneumoniae, N. meningitidis, Streptococci group B, L. monocytogenes, H. influenza (in community-acquired bacterial meningitis), meningococcal, H influenzae type b (Hib), and pneumococcal infections (in children) are the most common organisms responsible for bacterial meningitis (13) . The rate of death in untreated bacterial meningitis is nearly 100% (10).
Lower respiratory tract infections (LRTIs) including pneumonia, acute bronchitis, and chronic obstructive pulmonary diseases (COPD) remains as the commonest illnesses in the elderly people in the worldwide (14, 15) . As shown in many studies, S. pneumoniae is the most common bacterial etiologic agent of LRTIs followed by H. influenza, Legionella spp., and C.pneumonia respectively (16) . Main risk factor for these diseases is age, and annually about 5 million people die from acute infections of the respiratory tract (16) . So, in order to provide an appropriate guide in antimicrobial treatment of these deseases for physicians, identification of pathogens as well as their drug sensitivity patterns is very important (17) .
When the microbial load exceeds from capacity of the clearance of immune system, bacterial wound infections occurs. The most prevalent bacteria isolated from wound infections are S. aureus and P. aeruginosa, which are resistant to many antibiotics. Therefore, the management of these diseases is need (18) .
For decades, antimicrobial agents established as a useful way for effective treatment of bacterial infections, but the emergence of acquired resistance to antimicrobial drugs has become an important public health problem associated with serious consequences for the treatment of the bacterial infections (2) . bacterial isolates of 2320 inpatients and outpatients suspected to clinical infections were collected from different clinical sources including, urine, blood, cerebrospinal fluid, tracheal aspirate, and wound specimens. The patient infection classified as community or hospital-acquired infections based on the clinical examination by physicians and recorded data of patients. Patients with bacterial colonization after more than 48 hours of hospitalization were defined as hospital-acquired infections.
Isolation and identification of bacteria
Pathogens identification was performed by culture, morphological, and biochemical properties. For urine culture, the midstream specimens of all urine samples were collected and then inoculated within one hour after sampling on different culture media such as blood agar and Mac Conkey agar. Plates were incubated at 37°C for 24-48 hours depending on the microorganism type.
Blood samples (3-5 mL) were cultured into 5 mL brain heart infusion broth and incubated at 37°C for 24 hours. Then in order to isolate pure bacteria, they were sub-cultured on blood agar, chocolate agar, and Mac Conkey agar plates and incubated for 24 hours at 37°C.
For cerebrospinal fluid (CSF), samples cultured on blood agar supplemented with 5% horse blood or chocolate agar. Then plates were incubated at 37°C for 24-48 hours.
Tracheal aspirates and wound specimens were obtained with aseptic methods. These specimens cultured on blood agar, chocolate agar, and Mac Conkey agar and then incubated at 37°C for 24 hours in order to isolate lower respiratory tract colonizers and contaminant organisms of wound.
Biochemical tests were done depending on the type of isolated bacteria (Gram-positive or Gram-negative) from various samples. In order to identify Gram positive bacteria; Catalase, Coagulase, Novobiocin, Optochin disk, CAMP test (for S. agalactiae), and Esculin agar (for enterococci), and for Gram negative bacteria; Triple Sugar Iron (TSI), Indole, Citrate, Urea, Lysine Decarboxylase (LDC), Oxidase (for Pseudomonaceae), and motility were performed.
Antibiotic susceptibility test
The antimicrobial susceptibility test of isolates was performed on Muller Hinton agar by modified disk diffusion method (MDDM) according to the Clinical and Laboratory Standards Institute (CLSI) guideline (19) . For this purpose, suspensions of pure bacteria equivalent to standard 0. (cefotaxime), Cephalosporins 3 st (ceftazidime, ceftizoxime, cefexime, ceftriaxone), Nitrofurans (nitrofurantoin), Penicillins (piperacillin), Quinolones (ciprofloxacin and nalidixic acid ), Sulfonamides (trimethoprim-sulfamethoxazole), Glycopeptides (vancomycin), Macrolides (azithromycin) were performed. After plate incubation at 37°C for 24 hours, diameter of the zone of growth inhibition was evaluated based on CLSI guideline. We used E. coli (ATCC 25922) as control strain for antibiotic susceptibility testing.
Statistical analysis
The frequency of drug resistance was expressed as percentage. All statistical analyses were done by SPSS v.15 software. The proportions were considered statistically significant if P-value was less than 0.05.
Results
In this study, 1614 bacterial isolates from different clinical specimens (773, 273, 13, 408, and 147 isolates from urine, blood, cerebrospinal fluid, tracheal aspirate, and wound samples respectively) from inpatients and outpatients were collected. From 1614 bacterial isolates, 885 (54.8%) were obtained from female patients and 729 (45.2%) from male patients, with an age range of 15 to 73 years (P > 0.05). Also 22.1% (357 isolates) of all bacterial isolates were Gram-positive and 77.9% (1257 isolates) were Gramnegative. The most prevalent organisms in different samples are shown in Fig. 1 and 2 . E. coli 425 (62.5%), Klebsiella spp. 32 (22.6%), P. aeruginosa 32 (22.6%), Klebsiella spp. 3 (37.5%), P. aeruginosa 110 (31.4%), and P. aeruginosa 22 (27.8%), were the main Gram negative bacteria isolated from UTI, BSI, CSF, tracheal aspirate, and wound specimens respectively (Fig. 1) . Also, CoNS 40 (42.5%), S. aureus 68 (51.5%), S. aureus 2 (40%), S. aureus 23 (39.6%), S. aureus 30 (44.1%), were the main Gram positive bacteria isolated from UTI, BSI, CSF, tracheal aspirate, and wound specimens respectively (Fig. 2) . In our study, antibiotic susceptibility test was performed by modified disk diffusion method. Tables 1-5 showed the overall prevalence of resistance to the antimicrobial agents tested in Gram positive and Gram negative bacteria which isolated from various clinical specimens.
Finally, the main bacteria isolated from hospital-acquired infections (HAI) and community-acquired infections (CAI) were Acinetobacter spp. and E. coli respectively.
Discussion
The global spread of resistance to antibiotics among bacterial infections is a growing problem and results in a lot of attention following reports of international expansion of multi-resistant S. pneumoniae, meticillin-resistant S. aureus.and Enterobacteriaceae resistant to cephalosporins (20) . This phenomenon is one of the main challenges facing mankind public health in the worldwide and require global cooperation (21) .
In agreement with similar studies, our data showed that the prevalence of Gram negative bacteria, 1257 (77.9%), in different clinical infections was higher than Gram positive 357 (22.1%) pathogens (22) . Among bacterial infections investigated, urinary tract infection was more frequent (47.8%). Our study on UTI samples revealed that E. coli 425 (54.9%) and Klebsiella spp.79 (10.2%) were the most common organisms isolated and followed by Proteus spp. 61 (7.8%), CoNS 40 (5.1%), Enterobacter spp. 28 (3.6%), and Enterococcus spp. 28 (3.6%). Similar results have been reported by Farajnia et al. (5) . In the present study, the most of the urine specimens were obtained from outpatients (community-acquired infections). To assess drug resistance in all samples no differentiate were performed between bacteria isolated from community and hospital-acquired infections. The highest resistance rate of the E. coli isolates were against trimethoprimsulfamethoxazole 278 (65.4%) and nalidixic acid 235 (55.2%). The lowest resistance rates were against nitrofurantoin 24 (5.6%) and amikacin 42 (9.9%) ( Table 1) . These results are comparable with susceptibility profiles observed from other studies (5) . The highest and lowest resistance levels to nitrofurantoin were observed in Acinetobacer spp. (100%) and S. agalactiae. From 773 bacteria isolated of UTI, 485 (62.7%) were obtained from female patients and 288 (37.3%) from male patients. This result is comparable with Farajniaet al. report (5) . This suggests that UTI is an important problem in women. Isolation rate of bacteria in the blood specimens of suspected patients to BSI was 16.9% (P> 0.05). From 273 bacteria isolated of BSI, 108 (39.5%) were obtained from female patients and 165 (60.5%) from male patients. Similar to urinary tract infections, in blood stream infections the prevalence of Gram negative was higher than Gram positive bacteria (51.6% vs. 48.4%). As shown in Fig. 1 and 2 , S. aureus 68 (24.9%), Klebsiella spp. 32 (11.7%), P. aeroginosa 32 (11.7%), CoNS 31 (11.3%), Acinetobacter spp. 27 (9.8%), E. coli 26 (9.5%), S. viridans 18 (6.5%), Enterococcus spp. 13 (4.7%), S. typhi 8 (2.9%), S. marcescens 8 (2.9%), Enterobacter spp. 6 (2.1%), S. pneumonia 2 (0.7%) and S. maltophilia 2 (0.7%) were the most prevalent organisms causing BSI. Similar results have been reported in studies of Iranian, American, and European researchers (23) . Among Gram negative and positive bacteria isolated from blood infections the highest resistance rate found in S. maltophilia, Acinetobacer spp., and P. aeroginosa, which were resistant to most commonly tested antibiotics ( Table 2) . Table 2 : Antibiotic susceptibility profile of organisms isolated from BSIs. AN, amikacin; GEN, gentamicin; TMP-SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; CAZ, ceftazidime; CT, ceftizoxime; CFM, cefixime; PIP,piperacillin; IPM,imipenem; AZM, azithromycin; V, vancomycin; CRO-ceftriaxone; CTX, cefotaxime; CZ, cefazolin. *CoNS, Coagulase-Negative Staphylococci; NA, not applicable.
S. agalactiae (N=2)
0 (0) NA 0 (0) 1 (50) NA 0 (0) 1 (50) NA 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Prevalence of Bacterial Infections in Hamadan
We investigated 13 outpatients, from cerebrospinal fluid isolates of which 5 (38.4%) were Gram positive (S. aureus 40%, CoNS 20%, S. viridans 20%, and S. pneumonia 20%) and 8 (61.6%) were Gram negative (Klebsiella spp. 37.5%, E. coli 25%, P. aeroginosa 12.5%, Acinetobacter spp. 12.5%, and S. typhi 12.5%). The resistance rate to trimethoprimsulfamethoxazole and cefixime antibiotics in all bacterial pathogens isolated from CSF specimens was 100%, and also no resistance to vancomycin, ceftriaxone, and cefotaxime in Gram positive bacteria was observed (0%), which may act as good choices for the antimicrobial treatment (Table 3) . Table 3 . Antibiotic susceptibility profile of organisms isolated from CSF infections. Table 4 : Antibiotic susceptibility profile of organisms isolated from lower respiratory infection AN, amikacin; GEN, gentamicin; TMP-SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; CAZ, ceftazidime; CT, ceftizoxime; CFM, cefixime; PIP,piperacillin; IPM,imipenem; AZM, azithromycin; V, vancomycin; CRO-ceftriaxone; CTX, cefotaxime; CZ, cefazolin. *CoNS, Coagulase-Negative Staphylococci; NA, not applicable. Table 5 : Antibiotic susceptibility profile of organisms isolated from wound infections. AN, amikacin; GEN, gentamicin; TMP-SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; CAZ, ceftazidime; CT, ceftizoxime; CFM, cefixime; PIP,piperacillin; IPM,imipenem; AZM, azithromycin; V, vancomycin; CRO-ceftriaxone; CTX, cefotaxime; CZ, cefazolin. *CoNS, Coagulase-Negative Staphylococci; NA, not applicable.
